Syngeneic leukemia models using lentiviral transgenics
Open Access
- 18 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 12 (2), 1-13
- https://doi.org/10.1038/s41419-021-03477-2
Abstract
Animal models are necessary to study cancer and develop treatments. After decades of intensive research, effective treatments are available for only a few types of leukemia, while others are currently incurable. Our goal was to generate novel leukemia models in immunocompetent mice. We had achieved abilities for overexpression of multiple driving oncogenes simultaneously in normal primary cells, which can be transplanted and followed in vivo. Our experiments demonstrated the induction of primary malignant growth. Leukemia lines that model various types of leukemia, such as acute myeloid leukemia (AML) or chronic lymphocytic leukemia (CLL), were passaged robustly in congenic wild-type immunocompetent mice. These novel leukemia lines, which may complement previous models, offer the flexibility to generate tailored models of defined oncogenes of interest. The characterization of our leukemia models in immunocompetent animals can uncover the mechanisms of malignancy progression and offer a unique opportunity to stringently test anti-cancer chemotherapies.Keywords
Funding Information
- Israel Cancer Research Fund (16-1232-RCDA)
- Ministry of Science, Technology and Space (54180)
- MOST-DKFZ grant #CA-179.
This publication has 60 references indexed in Scilit:
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2012
- The Pathogenesis of Mixed-Lineage LeukemiaAnnual review of pathology, 2012
- Hematopoietic stem cell transplantation without irradiationNature Methods, 2009
- Initial treatment for patients with CMLHematology, 2009
- Nanoscale Increases in CD2-CD48-mediated Intermembrane Spacing Decrease Adhesion and Reorganize the Immunological SynapseOnline Journal of Public Health Informatics, 2008
- HOX expression patterns identify a common signature for favorable AMLLeukemia, 2008
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- Inducible expression of BCR/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndromeBlood, 2003
- GENETICS OF MYELOID LEUKEMIASAnnual Review of Genomics and Human Genetics, 2002
- Consequences of BCR‐ABL Expression within the Hematopoietic Stem Cell in Chronic Myeloid LeukemiaThe International Journal of Cell Cloning, 2000